Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy.

Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy.

Item
http://www.wikidata.org/entity/Q40568550
Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarineTargeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastropheThe rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesisBlockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemiaEffects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer CellsUBE1L represses PML/RAR{alpha} by targeting the PML domain for ISG15ylationThe histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells.Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models.A Preclinical Evaluation of Antrodia camphorata Alcohol Extracts in the Treatment of Non-Small Cell Lung Cancer Using Non-Invasive Molecular Imaging.In vitro activities of novel 4-HPR derivatives on a panel of rhabdoid and other tumor cell lines.A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation.Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas.Evidence for the ubiquitin protease UBP43 as an antineoplastic target.UBE1L causes lung cancer growth suppression by targeting cyclin D1.Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer
P2860

Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy.

Item
http://www.wikidata.org/entity/Q40568550
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Specific chemopreventive agent ...... tions for combination therapy.
@en
type
label
Specific chemopreventive agent ...... tions for combination therapy.
@en
prefLabel
Specific chemopreventive agent ...... tions for combination therapy.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Specific chemopreventive agent ...... tions for combination therapy.
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-03-0271
P407
P433
P478
P577
P698